2/14
07:08 pm
mrna
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
Low
Report
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
2/14
07:08 pm
mrna
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline [Yahoo! Finance]
Low
Report
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline [Yahoo! Finance]
2/14
04:26 pm
mrna
Moderna's Shot Sales, Canceled Contract Lead to Another Loss [Yahoo! Finance]
Neutral
Report
Moderna's Shot Sales, Canceled Contract Lead to Another Loss [Yahoo! Finance]
2/14
09:43 am
mrna
Moderna, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Moderna, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/14
08:01 am
mrna
Moderna stock down pre-market on mixed 2024 earnings [Yahoo! Finance]
Medium
Report
Moderna stock down pre-market on mixed 2024 earnings [Yahoo! Finance]
2/14
07:49 am
mrna
Moderna stock down pre-market on mixed 2024 earnings [Yahoo! Finance Canada]
Medium
Report
Moderna stock down pre-market on mixed 2024 earnings [Yahoo! Finance Canada]
2/14
06:48 am
mrna
Moderna posts bigger loss than expected as vaccine maker scales down manufacturing [Yahoo! Finance]
Medium
Report
Moderna posts bigger loss than expected as vaccine maker scales down manufacturing [Yahoo! Finance]
2/14
06:44 am
mrna
Moderna beats on revenue but loses more than expected as it scales down manufacturing [CNBC]
Medium
Report
Moderna beats on revenue but loses more than expected as it scales down manufacturing [CNBC]
2/13
11:09 am
mrna
Respiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider [Yahoo! Finance]
Medium
Report
Respiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider [Yahoo! Finance]
2/11
08:09 am
mrna
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Bank of America Co. from $41.00 to $34.00. They now have an "underperform" rating on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Bank of America Co. from $41.00 to $34.00. They now have an "underperform" rating on the stock.
2/7
10:02 pm
mrna
Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards? [Yahoo! Finance]
Low
Report
Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards? [Yahoo! Finance]
2/5
08:02 am
mrna
Why Moderna, Inc. (MRNA) Went Down on Tuesday [Yahoo! Finance]
Low
Report
Why Moderna, Inc. (MRNA) Went Down on Tuesday [Yahoo! Finance]
1/28
10:44 am
mrna
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $112.00 to $99.00. They now have a "buy" rating on the stock.
Medium
Report
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $112.00 to $99.00. They now have a "buy" rating on the stock.
1/27
10:42 am
mrna
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Evercore ISI from $60.00 to $50.00. They now have an "in-line" rating on the stock.
Medium
Report
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Evercore ISI from $60.00 to $50.00. They now have an "in-line" rating on the stock.
1/24
06:30 am
mrna
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Medium
Report
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
1/22
11:00 am
mrna
Moderna, Inc. (NASDAQ:MRNA) institutional owners may be pleased with recent gains after 65% loss over the past year [Yahoo! Finance]
Low
Report
Moderna, Inc. (NASDAQ:MRNA) institutional owners may be pleased with recent gains after 65% loss over the past year [Yahoo! Finance]
1/21
10:31 am
mrna
Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab [Yahoo! Finance]
Low
Report
Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab [Yahoo! Finance]
1/17
04:28 pm
mrna
Moderna Announces Updates on Pandemic Influenza Program
Low
Report
Moderna Announces Updates on Pandemic Influenza Program
1/16
04:15 pm
mrna
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Leerink Partners from $31.00 to $27.00. They now have an "underweight" rating on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Leerink Partners from $31.00 to $27.00. They now have an "underweight" rating on the stock.
1/16
04:15 pm
mrna
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at Berenberg Bank from $33.00 to $42.00. They now have a "hold" rating on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at Berenberg Bank from $33.00 to $42.00. They now have a "hold" rating on the stock.
1/15
10:19 am
mrna
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Morgan Stanley from $70.00 to $38.00. They now have an "equal weight" rating on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Morgan Stanley from $70.00 to $38.00. They now have an "equal weight" rating on the stock.
1/14
06:03 am
mrna
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/13
08:25 pm
mrna
Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion [MSNBC.com]
Low
Report
Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion [MSNBC.com]
1/13
11:30 am
mrna
Moderna cuts sales forecast on weaker vaccine demand [Yahoo! Finance Canada]
Medium
Report
Moderna cuts sales forecast on weaker vaccine demand [Yahoo! Finance Canada]
1/13
10:25 am
mrna
Moderna stock plunges 20% after company lowers 2025 sales forecast by $1 billion [MSNBC.com]
Medium
Report
Moderna stock plunges 20% after company lowers 2025 sales forecast by $1 billion [MSNBC.com]